eTherapeutics Company
eTherapeutics focuses on the discovery of cancer and degenerative diseases of the nervous system.
Founded Date:
2003-01-01
Total Funding:
112043919.0
Investor Type:
Company
Employee Number:
11-50
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
Post-IPO Equity
Technology:
Biotechnology, Health Care, Medical
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
1
Investors Number:
2.0
Last Funding Date:
2022-09-30
Industry:
Early Drug Development
Headquarters:
Hanborough, Oxfordshire, United Kingdom
Estimated Revenue:
Less than $1M